Welcome to our dedicated page for Panacea Life Sciences Hldgs news (Ticker: PLSH), a resource for investors and traders seeking the latest updates and insights on Panacea Life Sciences Hldgs stock.
Panacea Life Sciences Holdings Inc (PLSH) provides investors and industry stakeholders with comprehensive updates on its operations in hemp-derived phytocannabinoid manufacturing. This resource centralizes all official communications including regulatory filings, product development milestones, and operational expansions.
Key updates cover earnings reports, manufacturing process enhancements, and compliance achievements within evolving hemp industry regulations. Users will find detailed information on production capacity changes, sustainability initiatives, and third-party partnership announcements.
The curated news collection serves as a reliable reference for tracking PLSH's adherence to cGMP-certified production standards and its strategic positioning in competitive wellness markets. Content is rigorously verified to ensure factual accuracy and relevance to financial decision-making.
Bookmark this page for streamlined access to PLSH's latest developments, including analysis of market trends impacting hemp-based product manufacturers. Regular updates ensure stakeholders maintain current awareness of the company's operational and regulatory landscape.
Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. launched Benivita PLSH on November 18, 2025, a direct-to-consumer membership platform for non-insurance benefits, telemedicine, and lifestyle discounts.
The platform combines PLSH operations, Benivita marketing, and an exclusive license from New Benefits (serving >25 million members). Plans start at $59.95 monthly for individuals. Financials show projected EBITDA $1.2M (2026), $5.2M (2027), $8.3M (2028) and a target of 100,000 members within 36–60 months. PLSH will own 100% of the new LLC, issue 16M restricted shares to Benivita and up to 125M performance shares.
Panacea Life Sciences (PLSH) has signed a Supply, Licensing, and Development Agreement with Sky Wellness for the marketing and sale of CBD products. Sky Wellness will provide its current inventory, and Panacea will handle marketing and sales, splitting net sales revenue 60% to Sky Wellness and 40% to Panacea. The agreement allows Panacea to use Sky Wellness' trademarks and intellectual property for new product development, including CBD and non-CBD dog chews and a male enhancement product. Panacea plans to stock these products at its retail locations in Tampa, Florida.
FAQ
What is the current stock price of Panacea Life Sciences Hldgs (PLSH)?
What is the market cap of Panacea Life Sciences Hldgs (PLSH)?
